Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03252522 · ClinicalTrials.gov registry record · Phase 1
Micronutrients for Attention-Deficit Hyperactivity Disorder in Youth (MADDY) Study
A Phase 1 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 1
- Development phase
- 135
- Enrollment target
NCT03252522 is a Phase 1 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 135 participants.
The verdict
NCT03252522, a Phase 1 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 135 participants
- Enrollment target
Study Summary
This proposed research will use randomized control trial (RCT) methodology and compare micronutrients with placebo in 135 children with ADHD.
Interventions
- DIETARY_SUPPLEMENT Placebo
- COMBINATION_PRODUCT Broad Spectrum Micronutrients; a 36-ingredient blend of vitamins, minerals, amino acids, and antioxidants
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2018-04-23 |
| Est. Completion | 2021-05-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03252522
The ClinicalTrials.gov registry entry for NCT03252522 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03252522 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03252522 about?
NCT03252522 is a clinical study titled "Micronutrients for Attention-Deficit Hyperactivity Disorder in Youth (MADDY) Study". This proposed research will use randomized control trial (RCT) methodology and compare micronutrients with placebo in 135 children with ADHD.
What is the current status of trial NCT03252522?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 135 participants. The study started on 2018-04-23. Estimated completion is 2021-05-31.
What interventions are being tested in trial NCT03252522?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Broad Spectrum Micronutrients; a 36-ingredient blend of vitamins, minerals, amino acids, and antioxidants (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT03252522?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.